The future of sales: changes in the B2B operating model

Published on January 19, 2023

According to our latest research, megatrends are changing the face of business. But B2B confidence remains strong, and strategic investment in sales remains high for top performers.

Major shifts such as Covid, de-globalisation and digitalisation have brought about rapid change. To thrive, B2B companies need to adapt to the subsequent shifts in buyer behaviour. The key is to align strategy with new expectations, and be prepared for continuous change.

Our recent B2B study outlines how the landscape looks right now, and explains why some companies are getting it right.

B2B has a positive market outlook

The ongoing volatility in B2B is complex, as are the causes. Some industry segments like construction are being heavily impacted by high inflation, others like energy are sensitive to the war in Ukraine, yet others like hospitality are still recovering from Covid. Food and beverage is seeking sustainability, healthcare…

Continue reading on website
Other news

How Pharma can Overcome Barriers to CGT Diagnostic Testing

January 19, 2023
Diagnostic testing allows pharmaceutical companies to identify the right patients for cell and gene therapies to maximize therapeutic and commercial success. However, ensuring access to diagnostic testing is complex. Our experts provide insights on barriers pharma face and how to overcome them. Typically, cell and gene therapies (CGTs) tackle rare diseases with a relatively small, restricted patie

Perfecting Deposit Pricing in Rapid Rising Rate Environments

January 19, 2023
Retail banks around the world are grappling with rising interest rates, slowing economic growth, and market conditions that will pressure margins in the months ahead. How should banks approach deposit cost management to protect growth and profitability? Interest rates are rising fast and furious as central banks in developed markets scramble to slow historic levels of inflation.The US Federal Rese